Exodus Point Capital Management, LP Viking Therapeutics, Inc. Transaction History
Exodus Point Capital Management, LP
- $14.7 Billion
- Q2 2024
A detailed history of Exodus Point Capital Management, LP transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Exodus Point Capital Management, LP holds 274,500 shares of VKTX stock, worth $17.4 Million. This represents 0.1% of its overall portfolio holdings.
Number of Shares
274,500
Previous 29,400
833.67%
Holding current value
$17.4 Million
Previous $2.42 Million
502.19%
% of portfolio
0.1%
Previous 0.02%
Shares
14 transactions
Others Institutions Holding VKTX
# of Institutions
442Shares Held
63.3MCall Options Held
6.23MPut Options Held
2.97M-
Vanguard Group Inc Valley Forge, PA10.1MShares$639 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.03MShares$382 Million0.01% of portfolio
-
State Street Corp Boston, MA5.12MShares$324 Million0.01% of portfolio
-
Jpmorgan Chase & CO New York, NY2.25MShares$143 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA1.86MShares$118 Million0.01% of portfolio
About Viking Therapeutics, Inc.
- Ticker VKTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,688,496
- Market Cap $4.86B
- Description
- Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...